Beijing Tong Ren Tang Chinese Medicine Company Limited (FRA:TQR)

Market Cap	530.94M -34.8%
Revenue (ttm)	151.07M -20.8%
Net Income	40.24M -30.0%
EPS	0.05 -30.0%
Shares Out	n/a
PE Ratio	12.47
Forward PE	10.53
Dividend	0.04 (7.23%)
Ex-Dividend Date	Jun 12, 2026

Volume	600
Open	0.6100
Previous Close	0.6100
Day's Range	0.6100 - 0.6100
52-Week Range	0.5850 - 1.0100
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 16, 2026

About FRA:TQR

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine products to wholesalers and individuals. It operates through Hong Kong, Mainland China, and Overseas segments. The company also offers Chinese medical consultation and treatment services. It markets its products under the Tong Ren Tang brand name. It also operates retail outlets in Hong Kong and in other countries and regions in Asia, the Oceania, North America, and...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1669
• Employees: 763
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TQR

Financial Performance

In 2025, FRA:TQR's revenue was 1.51 billion, a decrease of -6.10% compared to the previous year's 1.61 billion. Earnings were 397.22 million, a decrease of -20.60%.

Financial numbers in HKD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error